US 6037337
Use of the enantiomers of ifosfamide in antitumor therapy for reducing side effects
expired A61KA61K31/675
Quick answer
US patent 6037337 (Use of the enantiomers of ifosfamide in antitumor therapy for reducing side effects) held by Darwin Discovery Limited expires Mon Mar 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Darwin Discovery Limited
- Grant date
- Tue Mar 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/675